You’re not alone: Sydney has a supportive Crohn’s and colitis community, made up of people with inflammatory bowel disease, families, volunteers, and more. Together, we share experiences, raise funds at the Gutsy Walk and heighten awareness.

There an estimated 220 people with Crohn’s disease or ulcerative colitis in the Sydney area. We understand the challenges you and your family may be facing – because we face them, too.
Two stones animated wearing sunglasses holding hands.

Group Peer Support Events

Our virtual group peer support program invites people affected by IBD to connect with and provide support to others living with or caring for someone with Crohn’s and colitis. Group sessions ...

 • 
Virtual
 • 
Speaker giving a presentation

Diet Interventions for IBD: The Anti-inflammatory Diet and Gut Microbiome

Join us to learn about the relationship between diet and inflammatory bowel disease (IBD), including dietary interventions that target the intestinal microbiome (community of microorganisms in the gut ...

 • 
Zoom (Online)
 • 
Young Adult Series logo

Young Adult Series (Virtual Event)

The Young Adult Series is a unique opportunity for youth 17 to 30 years of age that are living with Inflammatory Bowel Disease (IBD) to connect with others that know what it is like to live with Crohn ...

 • 
Zoom (Online)
 • 
Two stones animated wearing sunglasses holding hands.

Group Peer Support Events

Our virtual group peer support program invites people affected by IBD to connect with and provide support to others living with or caring for someone with Crohn’s and colitis. Group sessions ...

 • 
Virtual
 • 

Facebook

More on Facebook
 
Remember to bookmark this page.

News

“You don’t need to be superhuman”: How a small-town hockey player made it to the NCAA in the face of Crohn’s disease

“You don’t need to be superhuman”: How a small-town hockey player made it to the NCAA in the face of Crohn’s disease

Takeda Canada announces positive results for ENTYVIO® (vedolizumab) vs. Humira® (adalimumab) in first IBD study to compare biological agents head-to-head

Takeda Canada announces positive results for ENTYVIO® (vedolizumab) vs. Humira® (adalimumab) in first IBD study to compare biological agents head-to-head

 25 26 27 28 29 30 31 32 33 34